Fermented oyster extract (DrugBank: Oyster)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 84 | Sarcoidosis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04109911 (ClinicalTrials.gov) | September 25, 2019 | 27/9/2019 | Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults | Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults: a Randomized, Double-blinded, Placebo-controlled Trial | Muscular Sarcoidosis | Dietary Supplement: Fermented oyster extract;Dietary Supplement: Placebo | Pusan National University Yangsan Hospital | NULL | Recruiting | 50 Years | N/A | All | 54 | N/A | Korea, Republic of |